Molecules 2012, 17(10), 12365-12377; doi:10.3390/molecules171012365
Article

Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization

1 Department of Specialty Medicine, Ohio University, Athens, OH 45701, USA 2 Interthyr Corporation, Athens, OH 45701, USA 3 Biomedical Engineering Program, Ohio University Russ College of Engineering & Technology, Ohio University, Athens, OH 45701, USA 4 Department of Chemical and Biomolecular Engineering, Ohio University Russ College of Engineering & Technology, Ohio University, Athens, OH 45701, USA 5 Diabetes Institute, Ohio University College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA 6 Department of Biological Sciences, Ohio University College of Arts & Sciences, Ohio University, Athens, OH 45701, USA 7 Molecular & Cellular Biology Program, Ohio University College of Arts & Sciences, Ohio University, Athens, OH 45701, USA
* Author to whom correspondence should be addressed.
Received: 5 October 2012; in revised form: 16 October 2012 / Accepted: 19 October 2012 / Published: 22 October 2012
PDF Full-text Download PDF Full-Text [856 KB, Updated Version, uploaded 23 October 2012 12:05 CEST]
The original version is still available [856 KB, uploaded 22 October 2012 11:35 CEST]
Abstract: Previous studies revealed that phenylmethimazole (C10) inhibits IRF3 signaling, preventing dsRNA-induction of type 1 interferon gene expression, production, and downstream signaling. In the present study, we investigated the molecular basis for C10 inhibition of dsRNA-stimulated IRF3 signaling. IRF-3 Trans-AM assays were used to measure C10 effects on dsRNA induction of IRF3 DNA binding. Green fluorescent protein-labeled IRF3 was used to measure C10 effects on dsRNA-induced IRF3 nuclear translocation. Native PAGE, SDS PAGE, and western blotting were used to identify effects of C10 on IRF3 homodimer formation and phosphorylation, respectively. There was a significant impairment of dsRNA-induced IRF3 DNA binding activity in human embryonic kidney and pancreatic cancer cells with C10 treatment. C10 also blocked dsRNA-induced IRF3 nuclear translocation and homodimer formation without blocking serine 396 phosphorylation of IRF3. Together, these results indicate that C10 interferes with IRF3 signaling by blocking dsRNA-induced IRF3 homodimer formation, a prerequisite for nuclear translocation and DNA binding activities.
Keywords: phenylmethimazole (C10); IRF3

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Courreges, M.C.; Kantake, N.; Goetz, D.J.; Schwartz, F.L.; McCall, K.D. Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization. Molecules 2012, 17, 12365-12377.

AMA Style

Courreges MC, Kantake N, Goetz DJ, Schwartz FL, McCall KD. Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization. Molecules. 2012; 17(10):12365-12377.

Chicago/Turabian Style

Courreges, Maria C.; Kantake, Noriko; Goetz, Douglas J.; Schwartz, Frank L.; McCall, Kelly D. 2012. "Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization." Molecules 17, no. 10: 12365-12377.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert